Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension

Journal of the American College of Cardiology

Volumn 37, Issue 3, 2001, Pages 878-884

  Delles, Christian ^a   Erdmann, Jeanette ^b   Jacobi, Johannes ^a   Hilgers, Karl F ^a   Fleck, Eckart ^b   Regitz Zagrosek, Vera ^b   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SODIUM LOAD; SODIUM URINE LEVEL;

ADULT; ALDOSTERONE SYNTHASE; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; SODIUM;

EID: 0035281495     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01174-8     Document Type: Article

References (38)

1. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
2. Antihypertensive therapy - Going to the heart of the matter
3. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independent of blood pressure
4. Inadequate suppression of angiotensin II modulates left ventricular structure in humans
5. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
6. Left ventricular hypertrophy in asymptomatic essential hypertension: Its relationship with aldosterone and the increase in sodium-proton exchanger activity
7. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass
8. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
9. Mineralocorticoid, hypertension, and cardiac fibrosis
10. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hypertension
11. Purification and characterization of the activated mineralocorticoid receptor from rat myocardium
12. High affinity aldosterone binding sites (type I receptors) in rat heart
13. Detection of corticosteroid type I binding sites in heart
14. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart
15. Cloning of cDNA encoding steroid 11-beta-hydroxylase (P450c11)
16. Role of steroid 11-beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans
17. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyl-oxidase II deficiency
18. A chimaeric 11-beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
19. Haplotype analysis of CYP11B2
20. Association between aldosterone synthase gene polymorphism and the adrenocortical function in males
21. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
22. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function
23. Genetic determination of plasma aldosterone levels in essential hypertension
24. Structural analysis and evaluation of the aldosterone synthase gene in hypertension
25. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function
26. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
27. Left ventricular mass reduction during salt depletion in arterial hypertension
28. The effects of diet on echocardiographic left ventricular dimensions in normal man
29. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension
30. Standardization of M-mode echocardiographic left ventricular anatomic measurements
31. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
32. Dietary salt intake. A determinant of cardiac involvement in essential hypertension
33. Central blood volume: A determinant of early cardiac adaptation in arterial hypertension?
34. Clinical and hemodynamic determinants of left ventricular dimensions
35. Effect of the angiotensin II type 2-receptor (+1675 G/A) on left ventricular structure in humans
36. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake
37. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements